Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
mitchell
Article
Plugged-In: EV Collision Insights 2024 Year in Review
Do
Workers' Comp
Article
A Guide to Making Specialty Bill Review a Good Fit for You: An Account Manager's Perspective
In the complex world of medical bill review, specialty bill review stands out as a powerful tool for achieving significant savings.
mitchell
Conference
CSN Collision Conference 2025
The 2025 CSN Collision Conference is an engaging and informative gathering for industry professionals.
Workers' Comp
Article
Long-Term Catastrophic Assessments
Catastrophic injuries often require life-long medical care and a myriad of supportive services for injured employees.
Workers' Comp
Article
Third Party Litigation Funding: A Symptom of Deeper Issues in the Legal System
In the world of civil litigation, a new player has emerged—third-party litigation funders.
PC360
Article